📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant). (2021)

First Author: Irfan N

Attributed to: nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/acpj202105180-050

PubMed Identifier: 33939483

Publication URI: http://europepmc.org/abstract/MED/33939483

Type: Journal Article/Review

Volume: 174

Parent Publication: Annals of internal medicine

Issue: 5

ISSN: 0003-4819